Cancer Research UK logo.
SearchDonate
  • Search

A trial of docetaxel with or without dasatinib for prostate cancer that is no longer responding to hormone therapy (READY)

Overview

Cancer types:

Prostate cancer

Status:

Results

Phase:

Phase 3

Details

This trial looked at dasatinib and chemotherapy for prostate cancer that has spread to other parts of the body and is no longer responding to hormone therapy.

Recruitment start: 30 October 2008

Recruitment end: 11 April 2011

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Bruce Sizer

Supported by

Bristol-Myers Squibb

Last reviewed: 2 July 2014

CRUK internal database number: 3589

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.